The liver of obese patients with hepatic steatosis exhibits a severe dysregulation of key splicing machinery components as compared to obese patients without hepatic steatosis
Mercedes del Río-Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Raúl M. Luque(Instituto de Salud Carlos III), Manuel Rodríguez‐Perálvarez(Instituto Maimónides de Investigación Biomédica de Córdoba), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Sergio Pedraza‐Arévalo(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Rhonda D. Kineman(University of Illinois Chicago), Gustavo Ferrín(Instituto Maimónides de Investigación Biomédica de Córdoba), la Mata Manuel de, Sandra González‐Rubio(University of Córdoba)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients
|Transplantation|2017|309